Marc Schegerin

Chief Financial Officer & Head of Strategy at ArQule, Inc.

Marc Schegerin

Marc Schegerin

Chief Financial Officer & Head of Strategy at ArQule, Inc.

Biography

Dr. Schegerin currently serves as the Chief Financial Officer and Head of Strategy at ArQule. He joined ArQule in May 2018 from Citigroup where he served as a Healthcare Investment Banking Director. There, he was responsible for the sourcing, planning and execution of dozens of deals across biopharma globally, including M&A/Strategic Advisory and Debt and Equity offerings totaling more than $40bn. Prior to working at CitiGroup, Dr. Schegerin held healthcare investment banking positions at Merrill Lynch as Vice President and Goldman Sachs, where he began his banking career. Dr. Schegerin also served in multiple industry roles, first at Biogen in BD/Strategy, Clinical Development and Program Leadership where he led multiple programs, including aducanumab, and later at Sage Therapeutics where he was the Head of Program & Portfolio Management. Dr. Schegerin holds degrees from Tulane University and Harvard University. He received his M.D. from Dartmouth Medical School (Payson/Hampers Scholar) and M.B.A. from the Tuck School of Business at Dartmouth (Don Wilson III Scholar).

Overview
Career Highlights

ArQule, Inc.

RelSci Relationships

46

Relationships
RelSci Relationships are individuals Marc Schegerin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at ArQule, Inc.

Relationship likelihood: Strong

President & Chief Operating Officer at ArQule, Inc.

Relationship likelihood: Strong

Chief Medical Officer at ArQule, Inc.

Relationship likelihood: Average

Chief Financial Officer at Stealth BioTherapeutics Corp.

Relationship likelihood: Average

Former Executive Chairman of the Board & Interim Chief Executive Officer at EXACT Sciences Corp.

Relationship likelihood: Average

Executive Editor at Theology of Work

Relationship likelihood: Average

Co-Founder at Zebra Biologics, Inc.

Relationship likelihood: Average

Former Finance Director at Ciba Geigy Corp.

Relationship likelihood: Average

Senior Director-Business Development at ArQule, Inc.

Relationship likelihood: Average

Former Chief Medical Officer at The Multiple Myeloma Research Foundation, Inc.

Relationship likelihood: Average

Paths to Marc Schegerin
Potential Connections via
Relationship Science
You
Marc Schegerin
Chief Financial Officer & Head of Strategy at ArQule, Inc.
Career History
Chief Financial Officer & Head of Strategy
2018 - Current

ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751 and Derazantinib products. The company was founded in 1993 and is headquartered in Burlington, MA.

Other Affiliations

Marc Schegerin is affiliated with ArQule, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Marc Schegerin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Marc Schegerin's profile does not indicate a business or promotional relationship of any kind between RelSci and Marc Schegerin.